25 May 2013
Keywords: allergan, tazorac, effective, psoriasis, presented, results, phase
Article | 31 March 2003
Allergan has presented the results of two Phase III studies whichsupport the efficacy of its oral formulation of Tazorac (tazarotene) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
31 March 2003
24 May 2013
© 2013 thepharmaletter.com